
Burning Rock Biotech Investor Relations Material
Latest events

Q1 2024
Burning Rock Biotech

Q4 2024
25 Mar, 2025

Q3 2024
2 Dec, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Burning Rock Biotech Limited
Access all reports
Burning Rock Biotech Limited focuses on developing and providing next-generation sequencing-based cancer therapy selection tests. The company offers comprehensive genomic profiling services and products for cancer patients to guide treatment decisions. Its key services include liquid biopsy, tissue biopsy, and companion diagnostic development, aimed at improving clinical outcomes for cancer patients. Burning Rock Biotech serves sectors such as oncology, biotechnology, and personalized medicine, collaborating with medical institutions, pharmaceutical companies, and research organizations. The company is headquartered in Guangzhou, China, and its shares are listed on the NASDAQ.
Key slides for Burning Rock Biotech Limited


Q4 2024
Burning Rock Biotech Limited


Q4 2024
Burning Rock Biotech Limited
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
BNR
Country
🇺🇸 United States